# Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes

Study · id `cardio:ct-nct07278531` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07278531](<https://clinicaltrials.gov/study/NCT07278531>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07278531

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT07278531. Randomized; single masking; primary purpose supportive care. Start 2027-02 (anticipated); primary completion 2028-08-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT07278531, source copy `cardio:ctgov-nct07278531-2026-08-13`, retrieved 2026-10-26)
- Planned start: 2027-02 (anticipated) (ClinicalTrials.gov record NCT07278531, source copy `cardio:ctgov-nct07278531-2026-08-13`, retrieved 2026-10-26)
- Primary completion: 2028-08-31 (anticipated) (ClinicalTrials.gov record NCT07278531, source copy `cardio:ctgov-nct07278531-2026-08-13`, retrieved 2026-10-26)
- Completion: 2028-08-31 (anticipated) (ClinicalTrials.gov record NCT07278531, source copy `cardio:ctgov-nct07278531-2026-08-13`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07278531, source copy `cardio:ctgov-nct07278531-2026-08-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07278531-2026-08-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes
- Condition: Type 2 Diabetes
- Intervention (Device): Continuous Glucose Monitoring (CGM)
- Intervention (Behavioral): Adaptive dietary intervention (GEM)
- Lead sponsor: NYU Langone Health
- Lead sponsor class: OTHER
- Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: NYU Langone Health (`cardio:org-nyu-langone-health`)
- Registry lists this organization as a collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (`cardio:niddk`)

## Provenance

Content hash: 489d353d4650dc3a2f42bc289157f4ef9bd962c58f3f7ccadb5e67184cef2a0f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
